There's already some very strong research out of the US showing the autism link with A1 milk, and I would guess that the new study will build on that, to make it clearer to non-sciemtists.
Incidentally, the Nutrition Journal has pubished within the past few days a detailed clinical study based on results of the initial human trial conducted in China. Among other things it makes clear that a lot of the alleged weaknesses in this trial put forward by a handful of non-shareholder critics on this forum do not exist, including suggestions that the subjects were just imagining their lactose-intolerant symptoms.
The publication of such clinical trial results - to be followed by results from a much larger trial involving 600 human subjects - will put A2MC in a powerful position to counter critics and to affirm the scientific veracity of its case. It could be pretty useful when the Lion case comes to court. Can't see the claims by Lion getting far.
- Forums
- ASX - By Stock
- A2M
- 2 new studies from A2MC
2 new studies from A2MC, page-14
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.92 |
Change
0.110(2.29%) |
Mkt cap ! $3.562B |
Open | High | Low | Value | Volume |
$4.82 | $4.94 | $4.79 | $10.09M | 2.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $4.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.92 | 23558 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 4.890 |
2 | 6674 | 4.880 |
1 | 12000 | 4.870 |
9 | 58881 | 4.860 |
5 | 21511 | 4.850 |
Price($) | Vol. | No. |
---|---|---|
4.920 | 23558 | 2 |
4.930 | 50286 | 5 |
4.940 | 23143 | 2 |
4.950 | 7247 | 5 |
4.990 | 6530 | 3 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |